Medicenna Therapeutics Corp.

Verition Fund Management LLC MDNAF

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

555,392

Value ($000)

159

Weight

0.0%

2020 Q4 - 2023 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	159	0.0%	555,392	9/30/2023
2023 Q2	8/14/2023	282	0.0%	589,500	6/30/2023
2023 Q1	5/15/2023	392	0.0%	603,407	3/31/2023
2022 Q4	2/14/2023	253	0.0%	539,051	12/31/2022
2022 Q3	11/14/2022	447	0.0%	539,051	9/30/2022
2022 Q2	8/30/2022	631	0.0%	539,051	6/30/2022
2022 Q1	6/2/2022	685	0.0%	539,051	3/31/2022
2021 Q4	5/3/2022	879	0.0%	539,051	12/31/2021
2021 Q3	11/15/2021	1,493	0.0%	539,051	9/30/2021
2021 Q2	8/16/2021	1,623	0.0%	539,051	6/30/2021
2021 Q1	5/18/2021	2,199	0.0%	539,051	3/31/2021
2020 Q4	2/16/2021	2,526	0.0%	539,651	12/31/2020